US equities |
MU $889.88 ▼-4.44% TSLA $351.08 ▼-3.13% NVDA $214.90 ▼-1.07% AAPL $340.75 ▼-0.36% SPCX $144.27 ▼-2.93% META $706.17 ▼-4.15% MSFT $526.33 ▼-2.43% SNDK $1,319.89 ▼-5.37%
FinancialContent

Elite Pharms Inc (OP:ELTP)

0.2454 -0.0086 (-3.39%)
Delayed Quote Updated: 2:46 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elite Pharms Inc

< Previous 1 2 3 Next >
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
Via ACCESSWIRE
News headline image
7 Penny Stocks With Promising Potential Catalysts in 2024 ↗
Explore these top seven promising penny stocks set to soar as year-end approaches, offering stellar long-term upside ahead. 
Via InvestorPlace
News headline image
Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024 ↗
When it comes to stocks predictions for the current quarter, these seven penny stocks to buy could start or continue to crush it. 
Via InvestorPlace
News headline image
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
Via ACCESSWIRE
News headline image
7 Up-and-Coming Penny Stocks to Put on Your Must-Buy List ↗
These seven up-and-coming penny stocks represent strong growth opportunities, and all sport reasonable valuations. 
Via InvestorPlace
News headline image
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
Via ACCESSWIRE
News headline image
7 OTC Stocks to Buy With Boatloads of Potential ↗
A mix of value and growth plays, risk-tolerant investors should consider these seven OTC stocks with high potential. 
Via InvestorPlace
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information
Via ACCESSWIRE
News headline image
The 7 Best Penny Stocks for 10 Cents or Less ↗
If you are active in OTC stocks, and have a high risk appetite, consider these 7 penny stocks for 10 cents or less. 
Via InvestorPlace
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022
Via ACCESSWIRE
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT 
From Elite Pharmaceuticals, Inc.
Via AccessWire
News headline image
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)
NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced... 
From Elite Pharmaceuticals, Inc.
Via AccessWire
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022 
From Elite Pharmaceuticals, Inc.
Via AccessWire
News headline image
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
NORTHVALE, NJ / ACCESSWIRE / May 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,... 
From Elite Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
NORTHVALE, NJ / ACCESSWIRE / April 4, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced... 
From Elite Pharmaceuticals, Inc.
Via AccessWire
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information
Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty... 
From Elite Pharmaceuticals, Inc.
Via AccessWire
< Previous 1 2 3 Next >